KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $50.9 billion.

  • Eli Lilly's Total Non-Current Liabilities rose 3914.44% to $50.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50.9 billion, marking a year-over-year increase of 3914.44%. This contributed to the annual value of $36.1 billion for FY2024, which is 3952.63% up from last year.
  • Per Eli Lilly's latest filing, its Total Non-Current Liabilities stood at $50.9 billion for Q3 2025, which was up 3914.44% from $43.6 billion recorded in Q2 2025.
  • Eli Lilly's Total Non-Current Liabilities' 5-year high stood at $50.9 billion during Q3 2025, with a 5-year trough of $21.6 billion in Q4 2022.
  • In the last 5 years, Eli Lilly's Total Non-Current Liabilities had a median value of $26.1 billion in 2021 and averaged $30.0 billion.
  • As far as peak fluctuations go, Eli Lilly's Total Non-Current Liabilities tumbled by 1848.56% in 2022, and later skyrocketed by 4876.98% in 2024.
  • Over the past 5 years, Eli Lilly's Total Non-Current Liabilities (Quarter) stood at $24.6 billion in 2021, then dropped by 12.29% to $21.6 billion in 2022, then grew by 19.81% to $25.8 billion in 2023, then surged by 39.53% to $36.1 billion in 2024, then surged by 41.25% to $50.9 billion in 2025.
  • Its Total Non-Current Liabilities was $50.9 billion in Q3 2025, compared to $43.6 billion in Q2 2025 and $43.5 billion in Q1 2025.